+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Nutrition Market - Global Outlook and Forecast 2020-2025

  • ID: 5118919
  • Report
  • July 2020
  • Region: Global
  • 306 pages
  • Arizton
UP TO OFF
until Dec 31st 2020
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Anazaohealth Corporation
  • Baxter International Inc.
  • Exela Pharma Sciences
  • ICU Medical Inc.
  • Meiji Holding Co. Ltd.
  • MORE
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Clinical Nutrition Market Report

The global clinical nutrition market by revenue is expected to grow at a CAGR of over 8% during the period 2019–2025.

The global clinical nutrition market reached $51 billion in 2019 is expected to grow at a CAGR of 8% during the forecast period. The growing geriatric population, the increasing incidence of malnutrition, and the increasing prevalence of communicable and non-communicable chronic diseases across the globe are a few major factors driving the growth of the market.

Malnutrition is a widespread healthcare challenge, affecting the lives of millions of people around the world. A high incidence of malnutrition among hospitalized patients, especially in APAC, is driving the demand for clinical nutrition, which is considered as the most effective solution for patients to reduce the mortality rate.

The outbreak of novel coronavirus has been a global catastrophe. The symptoms of COVID-19 span a spectrum, ranging from mild, self-limiting flu to pneumonia, acute respiratory distress syndrome, and finally, death. A higher percentage of people have died in Europe than in Asia. A recent meta-analysis from China involving 46,248 patients showed that the most prevalent comorbidities in people infected by COVID-19 were hypertension, followed by diabetes, cardiovascular, and respiratory diseases.

The following factors are likely to contribute to the growth of the clinical nutrition market during the forecast period:
  • Increasing Use of Whey Protein in Clinical Nutrition
  • Growing Popularity of Home-based Healthcare
  • High Incidence of Malnutrition Among Hospitalized Patients
  • Enteral Nutrition Driving Market Growth
The study considers the present scenario of the clinical nutrition market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Clinical Nutrition Market Segmentation

The global nutrition market research report includes a detailed segmentation by route of administration, age group, application, end-users, distribution, and geography. The oral and enteral segment dominates a majority share of the market. The growing health awareness among consumers remains one of the key factors driving the growth of the market. This trend is expected to continue during the forecast period. Although clinical nutritional supplements are generally prescribed to individuals that are at high risk of malnutrition, oral supplements are witnessing widespread inclusions in dieticians’ recommendations.

The oral and enteral segment dominates a majority share of the market. The growing health awareness among consumers remains one of the key factors driving the growth of the market. This trend is expected to continue during the forecast period.

Although clinical nutritional supplements are generally prescribed to individuals that are at high risk of malnutrition, oral supplements are witnessing widespread inclusions in dieticians’ recommendations.

Hospitals constitute the largest end-user for clinical nutrition products globally. The rising incidence of chronic diseases, along with the growing number of preterm births and surgeries, has led to the growth of demand for clinical nutrition in hospitals.

Long-term care facilities (LTC) include includes ambulatory care facilities. The prevalence of protein-energy malnutrition in nursing homes residents range from 25–85%. Malnourishment in the elderly population can lead to poor clinical outcomes and increase the risk of mortality. Thus, clinical nutrition is generally recommended for patients in LTC facilities, which is driving growth.

Supermarkets and hypermarkets have been dominating the distribution landscape, and the channel is expected to continue its momentum during the forecast period. Drug stores and pharmacies are the most preferred outlets after supermarkets & hypermarkets. Countries such as India, China, and Japan are oriented toward supermarkets and traditional retail outlets. The other significant countries, such as Australia, depend keenly on drug stores and pharmacies.

Segmentation by Route of Administration
  • Oral or Enteral
  • Parenteral
Segmentation by Type
  • Pediatric
  • Adult
Segmentation by Application
  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Others
Segmentation by End-user
  • Hospital
  • LTC
  • Homecare
  • Individual
Segmentation by Distribution
  • Institutional Sales
  • Supermarkets & Hypermarkets
  • Pharmacy
  • Specialty Stores
  • Online Channels
  • Others
Insights by Geography

APAC accounts for the largest market share of the global clinical nutrition market. It is expected to witness the fastest growth during the forecast period. The large prevalence of metabolic disorders such as diabetes is boosting the demand for nutritional supplement products. China has the largest number of people who have diabetes globally, with around 116 million people in 2019. The proportion of cancer deaths in Asia is about 57.3% higher than the cancer incidence rate. Thus, with such a prevalence of chronic diseases, the demand for clinical nutrition products is expected to grow. The rise in the ageing population in the country is driving the medical nutrition market India.

North America was the second-largest clinical nutrition market accounting for 28% of the revenues in 2019. The US region is the major revenue contributor to the North America market. Due to the impact of COVID-19, the sales of medical nutrition products increased significantly in certain regions like China and the US.

Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • APAC
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • UAE
Insights by Vendors

The global clinical nutrition market share is fragmented and is highly competitive, with the presence of a large number of significant vendors in the market. The increasing demand for clinically proven formulas and scientific research is the major differentiating factor in the market than can substantially increase the level of investment required. As medical practitioners and pharmacists can serve as influencers for clinical nutrition products, vendors must establish a profitable relationship with them. Constant online engagement is necessary to increase influence among millennial and internet-oriented consumers as they consider online forums as a tool of suggestion and clarity. Collaborations with third-party vendors are crucial for market penetration.

Prominent Vendors
  • Abbott Laboratories
  • Business Overview
  • Major Product Offerings
  • Key Strengths
  • Key Strategies
  • Key Opportunities
  • Danone
  • Nestle Health Science
  • Baxter International Inc.
  • Braun
Other Prominent Vendors
  • Mead Johnson
  • Business Overview
  • Product Offerings
  • Fresenius Kabi
  • Perrigo Nutrition
  • ICU Medical Inc.
  • Otsuka Holding Co. Ltd.
  • Meiji Holding Co. Ltd.
  • Lonza Ltd.
  • Ajinomoto Cambrooke
  • Stepan Mead Johnson
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Grifols S.A
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • American Regent Inc
  • Exela Pharma Sciences
  • Avadel Pharmaceutical
  • Anazaohealth Corporation
  • BASF SE
Key Questions Answered
1. What is the market size and compound annual growth rate of the clinical nutrition market?
2. What are the emerging clinical nutrition market trends that is going to drive the industry during the forecast period?
3. What are the factors influencing the growth of the hospitals segment during the forecast period?
4. What is the growth of the adult and pediatric segment market shares by 2025?
5. Who are the major key players in the clinical nutrition market, and what are their market shares?
6. How is the growing population in the Asia Pacific region impacting the growth of the clinical nutrition market?
7. What is the impact of the COVID-19 pandemic on the global medical nutrition market size?
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Anazaohealth Corporation
  • Baxter International Inc.
  • Exela Pharma Sciences
  • ICU Medical Inc.
  • Meiji Holding Co. Ltd.
  • MORE
1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segmentation

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.2 Impact of Covid-19 On Global Clinical Nutrition Market

8 Market Opportunities & Trends
8.1 Increasing Use of Whey Protein in Clinical Nutrition
8.2 Growing Popularity of Home-Based Healthcare
8.3 Growing Demand for Parenteral Nutrition
8.4 Increased Demand in Developing Countries

9 Market Growth Enablers
9.1 High Incidence of Malnutrition Among Hospitalized Patients
9.2 Higher Nutritional Requirement Among Geriatric Population
9.3 Rising Incidence of Chronic and Metabolic Disorders
9.4 Increasing Preference of Enteral Over Parenteral
9.5 High Demand for Clinical Nutrition Among Cancer Patients

10 Market Restraints
10.1 Complications Related to Enteral Feeding
10.2 Stringent Regulations
10.3 Irregular Reimbursement Coverage for Clinical Nutrition

11 Market Landscape
11.1 Market Overview
11.2 Five Forces Analysis

12 Clinical Nutrition Market by Route of Administration
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Oral or Enteral
12.4 Parenteral

13 Clinical Nutrition Market by AGE Group
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Pediatric
13.4 ADULT

14 Clinical Nutrition Market by Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Malnutrition
14.4 Metabolic Disorders
14.5 Gastrointestinal Disorders
14.6 Cancer
14.7 Others

15 Clinical Nutrition Market by End-Users
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.4 LTC
15.5 Homecare
15.6 Individuals

16 Clinical Nutrition Market by Distribution Channels
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Institutional Sales
16.4 Supermarkets & Hypermarkets
16.5 Pharmacy And Drugstore
16.6 Specialty Stores
16.7 Online Channels
16.8 Others

17 Clinical Nutrition Market by Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview

18 APAC
18.1 Market Overview
18.2 Route of Administration
18.3 Age Group
18.4 Application
18.5 Distribution Channels
18.6 End-Users
18.7 Key Countries

19 North America
19.1 Market Overview
19.2 Route of Administration
19.3 AGE Groups
19.4 Application
19.5 Distribution Channels
19.6 End-Users
19.7 Key Countries

20 Europe
20.1 Market Overview
20.2 Route Of Administration
20.3 AGE Group
20.4 Application
20.5 Distribution Channels
20.6 End-Users
20.7 Key Countries

21 Latin America
21.1 Market Overview
21.2 Route of Administration
21.3 AGE Groups
21.4 Application
21.5 Distribution Channels
21.6 End-Users
21.7 Key Countries

22 Middle East & Africa
22.1 Market Overview
22.2 Route of Administration
22.3 AGE Group
22.4 Application
22.5 Distribution Channels
22.6 End-Users
22.7 Key Countries

23 Competitive Landscape
23.1 Competition Overview

24 Key Company Profiles
24.1 Abbott Laboratories
24.2 DANONE
24.3 Nestle Health Science
24.4 Baxter International Inc
24.5 B. BRAUN

25 Other Prominent Vendors
25.1 Mead Johnson Nutrition Company
25.2 Fresenius Kabi
25.3 Perrigo Company PLC
25.4 ICU Medical Inc.
25.5 Otsuka Holdings Co Ltd
25.6 Meiji Holdings Co. Ltd.
25.7 Lonza Ltd
25.8 Ajinomoto Cambrooke
25.9 Stepen Company
25.10 Basf SE
25.11 Reckitt Benckiser Group PLC
25.12 Sanofi
25.13 Grifols S.A
25.14 Sichuan Kelun Pharmaceutical Co., Ltd.
25.15 ICU Medical
25.16 American Regent Inc
25.17 Exela Pharma Sciences
25.18 Avadel Pharmaceutical
25.19 Anazaohealth Corporation

26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations

27 Quantitative Summary
27.1 Route of Administration
27.2 AGE Group
27.3 Application
27.4 Distribution Channels
27.5 End-Users
27.6 Geography
27.7 North America
27.8 APAC
27.9 Europe
27.10 Latin America
27.11 Middle East & Africa

28 Appendix
28.1 Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Laboratories
  • Danone
  • Nestle Health Science
  • Baxter International Inc.
  • Braun
  • Mead Johnson
  • Fresenius Kabi
  • Perrigo Nutrition
  • ICU Medical Inc.
  • Otsuka Holding Co. Ltd.
  • Meiji Holding Co. Ltd.
  • Lonza Ltd.
  • Ajinomoto Cambrooke
  • Stepan Mead Johnson
  • Reckitt Benckiser Group Plc
  • Sanofi
  • Grifols S.A
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • American Regent Inc
  • Exela Pharma Sciences
  • Avadel Pharmaceutical
  • Anazaohealth Corporation
  • BASF SE
Note: Product cover images may vary from those shown
5 of 5

Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...

Adroll
adroll